← back to database
We identify and invest in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of our industry.
Primary stage
Can also enter at
Lead / follow
Initial check size
Hardware / software
Investment focus
Investors
Barbara Dalton, Denis Patrick, Marie-Claire Peakman